You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 2.4% |
| Div Cover | n/a | 25.0 |
| Op Mrgn | 0.0% | 79.5% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -17.5 | 1.7 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 1.1 |
| Price / Book value | 3.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -3.40 | -3.06p | -4.5 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 5.03 | 1.63 | 1.92p | 5.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.10 | -4.10 | -3.45p | -3.8 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -4.79 | -3.53p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -17.73 | -9.46p | -16.2 | 0.0 | n/a | n/a | 0.0% |
| Synairgen drug proves effective against Covid variants in lab tests Sharecast News | 24 May |
|---|---|
| Synairgen confirms start of dosing in Covid-19 trial Sharecast News | 15 Feb |
| Synairgen enters clinical trial deal with US government Sharecast News | 25 Jan |
| Synairgen Notice of Interim Results | 21-Sep-21 07:00 |
|---|---|
| Holding(s) in Company | 10-Sep-21 11:30 |
| Exercise of Options and Total Voting Rights | 12-Aug-21 16:12 |
| Holding(s) in Company | 06-Aug-21 12:22 |
| Holding(s) in Company | 29-Jun-21 16:28 |